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Abstract
Background: Precise coordination of the hypothalamic-pituitary-gonadal axis orchestrates the normal reproductive
function. As a central regulator, the appropriate synthesis and secretion of gonadotropin-releasing hormone I (GnRH-I) from
the hypothalamus is essential for the coordination. Recently, emerging evidence indicates that histone deacetylases
(HDACs) play an important role in maintaining normal reproductive function. In this study, we identify the potential effects
of HDACs on Gnrh1 gene transcription.
Methodology/Principal Findings: Inhibition of HDACs activities by trichostatin A (TSA) and valproic acid (VPA) promptly
and dramatically repressed transcription of Gnrh1 gene in the mouse immortalized mature GnRH neuronal cells GT1–7. The
suppression was connected with a specific region of Gnrh1 gene promoter, which contains two consensus Otx2 binding
sites. Otx2 has been known to activate the basal and also enhancer-driven transcription of Gnrh1 gene. The transcriptional
activity of Otx2 is negatively modulated by Grg4, a member of the Groucho-related-gene (Grg) family. In the present study,
the expression of Otx2 was downregulated by TSA and VPA in GT1–7 cells, accompanied with the opposite changes of Grg4
expression. Chromatin immunoprecipitation and electrophoretic mobility shift assays demonstrated that the DNA-binding
activity of Otx2 to Gnrh1 gene was suppressed by TSA and VPA. Overexpression of Otx2 partly abolished the TSA- and VPA-
induced downregulation of Gnrh1 gene expression.
Conclusions/Significance: Our data indicate that HDAC inhibitors downregulate Gnrh1 gene expression via repressing
Otx2-driven transcriptional activity. This study should provide an insight for our understanding on the effects of HDACs in
the reproductive system and suggests that HDACs could be potential novel targets for the therapy of GnRH-related
diseases.
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Introduction
Normal reproductive function requires the precise orchestration
and integration of sex steroids secretion to effectively coordinate
the hypothalamic-pituitary-gonadal axis [1]. As the central
regulator, gonadotropin-releasing hormone I (GnRH-I) is pulsatily
secreted from some highly restricted, yet scattered particular nuclei
within the hypothalamus, and controls the synthesis and release of
luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
in pituitary [2,3]. Dysfunction or hyperfunction of GnRH neurons
leads to various pathophysiologic disorders, including infertility
[4], hypogonadotropic hypogonadism [5], hypothalamic amenor-
rhea [6] and central precocious puberty [7]. Despite GnRH
agonists/analogues and GnRH antagonists are widely applied in
clinic, these compounds still remain skepticism for some unsolved
issues, including pharmacokinetic, safety and commercial profiles
[8]. Therefore, elucidation of the exact molecular mechanisms
controlling Gnrh1 gene expression will improve our understanding
on abnormal gonadotropin secretion in various GnRH-related
disorders and provide new strategies for treatment of these
diseases.
Histone deacetylases (HDACs) have gained an increasing
attention for their crucial roles in numerous physiological and
pathological processes via dynamically regulating gene expression.
According to the profiles of global gene expression, a range of 2–
20% of genes in the genome is affected by HDAC inhibitors
(HDACIs) [9–11], indicating that a highly restricted set of cellular
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emerging evidence indicates the involvement of HDACs in
maintaining normal reproductive function. HDACs participate
in spermatogenesis [13], mediate Lhb and Fshb gene repression in
immature gonadotropes [14,15] and inhibit androgen receptor
transcriptional activity [16]. However, the exact roles of HDACs
in the modulation of neuronal function of GnRH neurons have
remained unclear and need to be further delineated.
So far, at least 18 HDACs have been identified in mammals, in
which they are divided into four classes based on their structure
and functions. Both Class I (HDACs 1–3 and 8) and class II
(HDACs 4–7 and 9–10) HDACs are Zn-dependent enzymes
which usually combine with other proteins to form a large multi-
protein complex that increases the stringency of HDACs re-
cruitment to a particular locus in chromatin to deacetylate histones
[14,17,18]. In the present study, we initially observed that Hdac1–
10 genes were co-expressed in the mouse immortalized GnRH
neuronal cells GT1–7, which are representative of mature
postmigratory GnRH neurons. Two HDAC inhibitors (HDACIs),
trichostatin A (TSA) and valproic acid (VPA), induced marked
inhibition of Gnrh1 gene transcription, and the suppression was
connected with a specific region of Gnrh1 gene promoter, which
contains two consensus Otx2 binding sites. Otx2, a vertebrate
homologue of Drosophila orthodenticle, has been demonstrated to
activate basal and also enhancer-driven transcription of Gnrh1
gene in several vertebrate species [19,20]. We hypothesized that
Otx2 may be involved in the HDACIs-induced attenuation of
Gnrh1 transcription. The analysis of transcript and protein levels
showed that Otx2 expression was simultaneously inhibited by
HDACIs treatments. Chromatin immunoprecipitation (ChIP) and
electrophoretic mobility shift assays (EMSA) demonstrated that
TSA and VPA induced the suppression of the DNA-binding
activity of Otx2 to Gnrh1 gene. Overexpression of Otx2 partly
abolished the TSA- and VPA-induced downregulation of Gnrh1
gene expression. In addition, Grg4 (Groucho-related-gene 4), a co-
repressor regulating Gnrh1 transcription, repressed the Otx2-
directed activation of Gnrh1 transcription by direct interaction with
Otx2. The increases in the expression of Grg4 and accumulation of
Grg4 protein in nuclei followed by HDACIs treatments also
supported our conclusion that HDACs regulate the Gnrh1 gene
transcription partly via modulating Otx2-driven transcriptional
activity.
Figure 1. HDACIs-induced repression of Gnrh1 gene expression in GT1–7 cells. (A) Expressions of endogenous Hdacs gene in GT1–7 cells
were determined by real-time PCR analysis. The value for the lower expression of Hdac10 was set as 1.0. (B) The Gnrh1 transcripts were quantified in
GT1–7 cells exposed to various concentrations of TSA or VPA with different times. TSA and VPA induced Gnrh1 transcripts in time- and dose-
dependent manners. The Gnrh1 mRNA in GT1–7 cells was significantly downregulated by 100 nM TSA and 4 mM VPA within 2 hours. Values for
control samples were set as 1.0. (C) Immunofluorescence staining of GnRH-I pre-peptide in GT1–7 cells was performed after treatments of TSA and
VPA for 24 hours. All the cultured cells were stained with FLuro 488 for the GnRH-I pre-peptide (green) or with DAPI for nuclei (blue). (D) GnRH-I pre-
peptide in the cells and GnRH-I mature peptide in cell culture media were measured by ELISA assay. Values for cells treated with vehicle were set as
100%. Bars represent 6 SD from three independent experiments. (n=3; *p,0.05, ** p,0.01; One-way ANOVA).
doi:10.1371/journal.pone.0039770.g001
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TSA and VPA significantly decreased the synthesis and
releases of GnRH-I in GT1–7 cells
The endogenous Hdac transcripts were detected in GT1–7 cells
by real-time PCR analysis, showing that Hdac1–10 genes were co-
expressed with Hdac1 and Hdac2 being the predominant
transcripts (Figure 1A). These results provided a basic evidence
for the potential roles of HDACs in regulating Gnrh1 expression.
The Gnrh1 transcripts in GT1–7 cells were noticeably repressed
in dose- and time-dependent manners following HDACIs treat-
ments (Figure 1B). When the cells were exposed to 100 nM TSA
and 4 mM VPA, the Gnrh1 transcripts decreased 44.6% and
35.5% within 2 hours, and markedly decreased 84.1% and 76.3%
24 h after HDACIs treatments, respectively. Moreover, the results
were confirmed by the immunofluorescence staining (Figure 1C)
and ELISA assay (Figure 1D), showing that HDACIs induced
significant decreases in the concentrations of intracellular GnRH-I
pre-peptides in GT1–7 cells and secretions of GnRH-I mature
peptides in cell culture media 24 h after co-incubation with
HDACIs.
TSA and VPA repressed Gnrh1 gene transcription
Cell cycle arrest and cytotoxicity have been known to repress
gene expression. In order to eliminate the cytotoxicity of the drugs,
the dying cells and cell viability were detected by flow cytometric
analysis (Figure 2A) and MTT assay (Figure 2B), respectively. The
cell cycle progression was detected by propidium iodide (PI)
staining (Figure 2C). The results showed that the cell cycle
progression and viabilities were not affected by treatments with
100 nM TSA or 4 mM VPA for 24 h. Since only dead cells can be
detected by PI staining, Hoechst 33258 staining (Figure 2D) was
used to enumerate apoptotic nuclei. The data showed that the
apoptosis cannot be induced by both of the inhibitors at the given
concentrations.
The levels of gene transcripts in the cells were determined by the
rates of mRNA synthesis and decay. Actinomycin D (AcD), an
RNA polymerase inhibitor, was used to investigate whether
HDACIs influence Gnrh1 gene transcription or mRNA stability.
Our results showed that Gnrh1 transcripts decreased to half at 3 h
when only AcD was present (Figure 2E). Pretreatment with AcD
for 1 hour almost completely blocked the TSA- and VPA-induced
decreases in Gnrh1 transcripts, suggesting that TSA and VPA
repressed Ghrh1 gene transcription individually rather than
affected mRNA stability.
HDACIs-induced suppression of Gnrh1 gene transcription
was connected to a specific region of Gnrh1 gene
promoter
The mouse Gnrh1 gene contains four exons and three introns,
and simultaneously encodes the GnRH-I decapeptide and the
initial amino acids of GnRH-associated peptide (GAP) [3,21,22]
Figure 2. HDACIs-induced inhibiton of Gnrh1 gene transcription. (A–D) Effects of HDACIs on cytotoxicity, cell cycle progression and
apoptosis. (A) Cytotoxicities of HDACIs were detected by flow cytometric (n=3) and (B) the survival rates of the cells were detected by MTT assay
(n=10). (C) The effects of HDACIs on cell cycle progression were analyzed by PI flow cytometry assays (n=3). There is no difference among the
groups (One-way ANOVA). (D) The apoptosis of the GT1–7 cells treated with HDACIs for 24 h was detected by Hoechst 33258 fluorescent staining.
The number of cells present in each image was 50–100. The percentage of apoptotic cells was calculated by dividing the numbers of cells with bright
and small nuclei with the total numbers of cells in the image. There is no difference among the groups (n.10, One-way ANOVA). (E) HDACIs inhibited
Gnrh1 gene transcription rather than decreased the stability of Gnrh1 mRNA. GT1–7 cells were pretreated with 0.01 mM AcD for 1 hour prior to the
addition of HDACIs. The arrow represents the point of time for adding HDACIs. The mRNA level was examined by real-time RT-PCR. The value for
sample treated by AcD at 0 h was used as control and set as 1.0. (n=3).
doi:10.1371/journal.pone.0039770.g002
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gene is located between 23446 bp to +28 bp [20,23]. We
generated a series of deletion mutants of the promoter as well as
introns 1–3 of the mouse Gnrh1 gene in the pGL3 reporter system
to identify the corresponsive region (Figure 3B & D). As shown in
Figure 3C, TSA and VPA noticeably inhibited the Gnrh1 promoter
activity by 91.2% and 80.5%, respectively, after 24 h treatments.
Unexpectedly, TSA and VPA upregulated the reporter gene
activities by 90.4% in intron 3 and 74.6% in intron 2, respectively,
suggesting some potential regulatory elements in introns 2 and 3
mediated the enhancement of Gnrh1 expression in the presence of
HDACIs (Figure 3C).
In the promoter segment deletion analysis (Figure 3D), when the
promoter was deleted to 22087 bp and 2520 bp, the luciferase
activities in GT1–7 cells were noticeably decreased without
HDACIs treatments, suggesting that potential enhancer elements
located in the regions (23446,22087 bp and
21134,2520 bp). When the promoter was deleted to
2249 bp, the luciferase activities downstream were near the value
in control group, indicating that the 107-base pair fragment
(2356,2249 bp) is the minimum promoter mediating Gnrh1
expression in GnRH neurons. The result was consistent with the
results of Kim’s report, and the 107 bp fragment contains two
Otx2 binding sites [20]. As shown in Figure 3E, in the deletion
mutant up to 21334 bp, the luciferase activities were dramatically
inhibited by TSA and VPA (88.4% and 82.1%, respectively). But
when deleted to 2356 bp, the luciferase activities gradually
recovered to 41.9% and 56.8%, respectively. The data suggested
that the region between 21134 and +23 bp mediated the
repression, and approximate half of the inhibition was mediated
by the region (2356,+23 bp). A similar tendency in the change of
luciferase activities was observed in GT1–7 cells exposed to VPA
(Figure 3E), suggesting that the class I HDACs regulate Gnrh1
expression through the Gnrh1 promoter region.
TSA and VPA induced acetylation of histone H3 in the
specific region of Gnrh1 promoter
Hyperacetylation of histones could open the compacted
chromatin to induce transcription activation. Defined by DNase
I sensitivity and histone H3 acetylation and methylation assays,
Larder and his colleagues show that the activation of Gnrh1
transcription in GT1–7 cells is due to the active chromatin statue
of the regulatory region in promoter [24]. Therefore, the
acetylation of histone H3 was detected in the cells following
HDACIs treatments. Western blot analysis showed that acetylated
histone H3 expression was significantly elevated in GT1–7 cells
treated with TSA or VPA (Figure 4A). To characterize such
regulatory region with better resolution, ChIP assay was
performed to examine the acetylation alteration within the
promoter sequence identified by reporter gene assay. The PCR
Figure 3. HDACIs-induced inhibition of Gnrh1 gene transcription associated with a specific region of Gnrh1 gene promoter. (A)
Schematic representation of the parts of the mouse Gnrh1 gene and mRNA [3]. The effects of promoter (B) and introns (D) on basal Gnrh1 expression
were evaluated by the values of firefly/renilla luciferase activities. The insets in (D) show schematic diagram about constructions of reporter plasmids
used in promoter segment deletion analysis (Left) and the elements contribute to the hypothalamus-specific expression of Gnrh1 (above). The
changes of luciferase activities mediated by TSA (C) and VPA (E). The changed folds were calculated by dividing the value of Firefly/Renilla luciferase
activity in each group exposed to HDACIs with the value obtained from the group transfected with the same reporter constructs exposed to vehicle.
Values for empty vector transfected groups were used as controls and were set as 1.0. (n=3; *p,0.05, ** p,0.01; One-way ANOVA).
doi:10.1371/journal.pone.0039770.g003
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upon TSA and VPA treatments occurred in the regions
(21196,+24 bp) in Gnrh1 promoter, respectively (Figure 4B).
HDACIs inhibited the transcriptional activity of Otx2
Otx2 is critical for basal and neuronal specific expression of
Gnrh1 [20]. In the presence of TSA and VPA, Otx2 transcripts
were dramatically repressed in GT1–7 cells in dose- and time-
dependent manners (Figure 5A). When the cells were exposed to
100 nM TSA or 4 mM VPA, Otx2 transcripts reduced 28.0% and
20.1% within 2 hours, and significantly decreased 64.9% and
49.3% 24 h after HDACIs treatments, respectively. The Otx2
protein levels were also obviously reduced in GT1–7 cells showed
by western blot analysis (Figure 5B) and immunofluorescence
staining (Figure 5C).
Figure 4. Determination of acetylation level of histone H3 in the promoter of Gnrh1 gene induced by TSA or VPA. (A) The TSA or VPA-
induced acetylation of histone H3 was confirmed by western blot analysis with an anti-acetylated histone H3 (AcH3) and histone H3 antibody. (B) The
degree of acetylation of histone H3 in Gnrh1 promoter was identified by ChIP analysis. Immunoprecipitation was performed with an anti-AcH3
antibody.
doi:10.1371/journal.pone.0039770.g004
Figure 5. Effects of HDACIs on Otx2 expression in GT1–7 cells. (A) Expression of Otx2 mRNA was significantly repressed by TSA (left) and VPA
(right) treatments in dose and time-dependent manners using real-time PCR analysis in GT1–7 cells. Values for control samples were set as 1.0. (n=3).
(B) and (C) The protein levels of Otx2 in GT1–7 cells 24 h after HDACIs treatments were determined by western blot (B) and immunofluorescence
staining (C), respectively. All the cultured cells were stained with FLuro 488 for the Otx2 protein (green) or with DAPI for nuclei (blue).
doi:10.1371/journal.pone.0039770.g005
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the concentrations of Otx2 proteins in cells nuclei were obviously
reduced (Figure 6A). The results of ChIP assay showed that the
binding ability of Otx2 to neuron-specific elements
(2356,2249 bp) in Gnrh1 promoter obviously decreased after
HDACIs treatments (Figure 6B). To further analyze the affinities
of Otx2 to the two conserved binding sites in mouse Gnrh1
promoter respectively, EMSA was performed with probes contain-
Figure 6. Otx2-mediated transcription activation of Gnrh1 gene modulated by HDACs. (A) Accumulation of Otx2 in nuclei was repressed
by HDACIs in GT1–7 cells. The affinity of Otx2 to the proximal Gnrh1 gene promoter was suppressed by HDACIs determined by ChIP (B) and EMSA
analysis (C). EMSA was performed with GT1–7 nuclear protein extracts using the DNA probes containing the Otx2-binding sites in the mouse Gnrh1
promoter. A supershifted protein complex (SS) was observed on both probes after addition of an Otx2 antibody. A 200-fold excess of unlabeled
probes didn’t eliminate binding of Otx2 to both probes (complex 2). Complex 1, 3 and 4–6 might non-specific binding. (D) Western blot analysis of
protein extracts obtained from GT1–7 cells transfected with pcDNA
TM 3.1/myc-His C empty vector or Otx2-myc-His/pcDNA3.1 expression vector. (E)
HDACIs-induced dowenregulation of Gnrh1 mRNA was partly rescued by overexpression of Otx2. The value for empty vector transfected control
group without drug treatment was set as 1.0. (n=3; *p,0.05, ** p,0.01; Unpaired t-test).
doi:10.1371/journal.pone.0039770.g006
Figure 7. Effects of HDACIs on Grg4 co-repressor in GT1–7 cells. (A) Grg4 transcripts were significantly elevated following TSA (left) and VPA
(right) treatments in dose and time-dependent manners using real-time PCR analysis in GT1–7 cells. Values for control samples were set as 1.0. (n=3).
(B) The total protein levels and (C) nuclear protein levels of Grg4 in GT1–7 cells 24 h after HDACIs treatments were determined by western blot.
doi:10.1371/journal.pone.0039770.g007
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(Figure 6C, above). In GT1–7 cells, Otx2 bound to both the
probes (Figure 6C, complex 2) and the Otx2 antibody caused
a supershift of this complex (Figure 6C, complex SS). Unexceptly,
the complexes 4 and 5 did not disappear in competition with
excess unlabeled probes, and the densities of the complexes were
significantly increased in the presence of HDACIs (Figure 6C),
suggesting that certain proteins or complexes bind to the regions of
Gnrh1 promoter surrounding the confirmed Otx2 consensus sites
and be involved in the HDACIs-induced attenuation of Gnrh1
transcription.
Otx2 overexpression was induced by Otx2-myc-His/pcDNA3.1
transfected in GT1–7 cells (Figure 6D), which could partly rescue
the suppression of Gnrh1 mRNA induced by HDACIs (Figure 6E).
All the results showed that the downregulation of Gnrh1 expression
was paralleled with the decrease in Otx2 expression and repression
of its function.
Groucho-related-gene 4 (Grg4) has been demonstrated to
directly interact with Otx2 to repress Otx2-directed activation of
Gnrh1 transcription in GT1–7 cells [24]. In this study, the results
showed that the expression of Grg4 was elevated in dose- and time-
dependent manners in the presence of HDACIs (Figure 7A).
Twenty-four hours after incubation with 100 nM TSA or 4 mM
VPA, Grg4 transcripts were increased by 58.6% and 57.2%,
respectively. The Grg4 protein levels (Figure 7B), especially the
concentrations of Grg4 proteins in cell nuclei (Figure 7C) were
obviously upregulated in GT1–7 cells 24 h after HDACIs
treatments, indicating that the Grg4-mediated repression was
enhanced.
Discussion
Conceptually, hyperacetylation of lysines in the core histones
would enhance gene expression via opening the chromatin
structure and easily recruiting transcription-associated proteins to
the DNA template. Thus, it is counterintuitive that HDACIs
would repress a gene expression rather than activate it. However,
a small number of genes, including p16 [11], Bcl-2 [25], Vegf
[26,27] and Wt1 [12], have been shown to be downregulated by
HDACIs. Here, we report that Gnrh1 belongs to the class of genes
that are downregulated by the TSA and VPA. TSA, a pan-HDAC
inhibitor, inhibits both class I and II HDACs. VPA, a potent anti-
convulsant and a short-chain fatty acid, acts as a selective class I
HDAC inhibitor that especially inhibits HDACs 1, 2, 3 and 8 in
a millimolar range without influencing the activities of HDACs 6,
7 and 9 [18]. Thus, our results indicate that at least class I HDACs
regulated Gnrh1 expression. Based on the rapid downregulation of
Gnrh1 transcripts within 2 hours, we could presume that the
suppression of Gnrh1 expression is an early event following
HDACIs treatments.
There may be two possibilities for the HDACIs-induced
repression of Gnrh1 expression: directly downregulating the Gnrh1
transcription, or influencing mRNA stability to promote mRNA
degradation. To rule out the second possibility, the RNA
polymerase inhibitor AcD is used to inhibit gene transcription.
In our study, the results show that the half-life of Gnrh1 mRNA
may be about 3 hours. TSA and VPA do not induce Gnrh1 mRNA
degradation and Gnrh1 mRNA downregulation required ongoing
RNA synthesis.
The elements in the promoter driving tissue-specific expression
of mouse Gnrh1 have well been characterized [3,28]. A distal
enhancer (23446,22087 bp) and the proximal promoter
(2346,+28 bp) have been identified as crucial regions for
hypothalamic Gnrh1 expression [20,23], which is confirmed by
the promoter segment deletion analysis. In the present study, we
have demonstrated that HDACIs-induced inhibition of Gnrh1
transcription in GT1–7 cells is associated with a specific region
(21134,+23 bp) in Gnrh1 gene promoter and the region between
2356 bp and +23 bp mediates a half of suppression.
It has been demonstrated that the Gnrh1 transcription is
associated with the chromatin status of the regulatory region in
Gnrh1 promoter. Larder and colleague believed that compared to
the non-neuronal NIH3T3 cells and immature GnRH neuronal
cells (GN11), the acetylation of histone H3 in Gnrh1 promoter in
GT1–7 is responsible for the activation of Gnrh1 transcription via
remodeling the chromatin and recruiting transcription factors
[24]. In the present study, the acetylation of histone H3
significantly has been shown to be increased in GT1–7 cells
incubated with TSA or VPA. ChIP assay show that histone H3 in
the region between 21196 and +24 bp in Gnrh1 promoter is highly
acetylated in the presence of TSA or VPA. Thus, it is
counterintuitive that the expression of Gnrh1 is inhibited by
HDACIs via the direct effects of HDACs on Gnrh1 promoter. In
the previous studies, little progress has been achieved in clarifying
the exact molecular mechanisms of HDACIs-induced attenuation
of gene transcription. Some studies show that increased acetylation
of histones in regulatory region would lead nucleosomes move and
remodel in specific loci to mask critical cis-acting sites and repress
gene expression [12]. The enhancer and silencer regions in genes
with different extents of acetylation modified by HDACs may
recruit more repressor [12]. Moreover, the HDACs-mediated
alternations of transcription factors/repressor expression and
function have been emphasized in the modulation of gene
transcription [29]. These transcriptional regulatory proteins
include p53 [30], p21 [31], NF-kB [32] and E2F1 [33]. Based
on the hyperacetylation of histone H3 in Gnrh1 promoter in the
presence of HDACIs, the mechanism mentioned above may be
more crucial for the repression.
There are two conserved binding sites for Otx2 in the certain
region identified by reporter gene assay [20]. Otx2 increases the
basal and enhancer-driven Gnrh1 gene transcription [19,20].
During embryogenesis [34] and adulthood [19,35], Otx2 is
colocalized with GnRH-I and regulates the maturation of GnRH
neurons and the appropriate synthesis of GnRH-I. Deficiency of
Otx2 is responsible for human hypogonadotropic hypogonadism
[36]. Recently, Chen and colleagues report that the Otx2
transcripts in explanted cultures of newborn murine retinae are
dramatically repressed by TSA or VPA [37]. In our present study,
the Otx2 transcripts in GT1–7 cells are suppressed by TSA or VPA
in dose- and time-dependent manners within 2 hours, which is
consistent with the changes of Gnrh1 expression. Meanwhile,
western blot analysis and immunofluorescence staining assay
demonstrate that TSA and VPA induce obvious decreases in the
intracellular protein level and the nuclear translocation of Otx2.
The results from ChIP and EMSA assays show that the affinity of
Otx2 to Gnrh1 gene promoter is significantly inhibited by
HDACIs, which may be due to the less Otx2 expression and less
Otx2 protein accumulated in nuclei. The HDACIs-induced the
decrease in Gnrh1 mRNA was partly reversed via overexpression of
Otx2. The exact mechanisms of HDACIs-induced downregulation
of Otx2 expression have remained unclear and need to be further
delineated. Based on the above results, we reasonably conclude
that Otx2-driven transcription activation of Gnrh1 gene is partly
modulated by HDACs.
Moreover, emerging evidence has shown that interactions
between Otx2 and cofactors regulate Otx2 transcriptional activity
[38–40]. Grg4, a member of the Groucho-related gene family, has
a glycine/prolin-rich region to recruit HDACs. Many studies show
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independent mechanism. Recently, it has been demonstrated that
Grg4 represses Otx2-directed activation of Gnrh1 transcription in
GT1–7 cells via physically interacting with Otx2 rather than
recruiting HDACs [24]. In our present study, we observe that Grg4
expression is regulated by HDACs, showing that the expression of
Grg4 is upregulated by TSA and VPA in dose- and time-dependent
manners. Inconsistent with rapid attenuation of Gnrh1 and Otx2
transcription within 2 hours after HDACIs treatments, the Grg4
transcripts is slowly elevated, indicating the limited effect of Grg4
on the early inhibition of Gnrh1 transcription induced by HDACIs.
The accumulation of Grg4 protein in nuclei induced by HDACIs
may repression the Otx2-induced transcriptional activation, and
the results may explain the phenomenon of a part reverse in Gnrh1
mRNA mediated by exogenous Otx2 with HDACIs treatments.
All the results suggest that a potential modulation effect of HDACs
on Otx2-induced activation of Gnrh1 transcription may be via
Grg4-dependent repression. In addition, in the present study,
EMSA show that the intensities of two top bands are obviously
increased following HDACIs treatments, suggesting that the
suppression of Gnrh1 expression might be mediated by proteins
or complexes which bind to the regions of Gnrh1 promoter
surrounding the confirmed Otx2 consensus sites. Therefore,
further studies should be conducted to identify the potential
trans-acting factors which are responsible for the HDACs-induced
suppression of Gnrh1 expression or co-repressor which inhibit Otx2
function. Grg4 may be a candidate of these proteins.
In summary, to our knowledge, the present study provides
evidence for the first time that (1) TSA and VPA repress Gnrh1
gene transcription, (2) the HDACIs-induced repression is related
to a specific region of the Gnrh1 gene promoter (21134,+23 bp),
which contains two consensus Otx2 binding sites, (3) the Otx2-
directed activation of Gnrh1 gene transcription is modulated by
HDACs. This study has complemented the potential roles of
HDACs in the regulation of the reproductive system and suggests
a potential avenue for the anti-GnRH therapies in the future.
Materials and Methods
Chemicals
Trichostatin A (TSA), valproic acid (VPA), and actinomycin D
(AcD) were purchased from Sigma Chemical Co. TSA, actino-
mycin D, cycloheximide were diluted in dimethyl sulfoxide
(DMSO), and VPA was diluted with phosphate buffered saline
(PBS).
Cell culture and drug treatment
The mouse immortalized GnRH neuronal cell line GT1–7
[19,41,42] (kindly provided by Dr. Pamela Mellon, Salk Institute
for Biological Studies, USA) was grown under routine conditions.
When the cells reached to 70–80% confluence, they were
separately treated with TSA and VPA. In the experiments
involving AcD treatments, the cells were pretreated with
0.01 mM AcD for one hour prior to the addition of 100 nM
TSA and 4 mM VPA.
mRNA extraction and RT-PCR
Total RNA was isolated and reverse transcribed to cDNA by
M-MLV reverse transcriptase (Invitrogen). The real-time quanti-
tative PCR reactions were carried out with SYBRH Premix Ex
Taq
TM II real-time PCR kit (Takara, Japan). The primers used are
listed in Table S1. The mRNA level of GAPDH in each sample was
used as an internal control. Relative quantities were analyzed by
the 2
2DDCt method. In most case, the samples with vehicle
treatment were used as controls (set as 1.0). All reactions were
carried out in duplicate.
Enzyme linked immunosorbent assay (ELISA)
The GT1–7 cells were incubated with serum-free DMEM for
24 h to synchronize the cell cycles. Subsequently, twenty four
hours after co-incubation, supernatants (medium) and cells were
harvested. The cells were lysed in 100 ml PBS containing 0.1%
Triton X-100 at 0uC [42]. Supernatants and lysates were assayed
for GnRH-I by the Luteinizing Hormone-Releasing Hormone
(LH-RH) EIA Kit (Phoenix pharmaceuticals) according to the
manufacturer’s recommendations.
Immunofluorescence
Twenty-four hours after HDACIs treatments, the cells were
fixed with 4% paraformaldehyde in PBS and permeabilized with
1% Triton X-100 for 30 min, and then blocked with 3% BSA and
1% Triton for 15 min. Following incubation with anti-GnRH-I
(1:20, Santa Cruz) or anti-Otx2 (5 mg/ml, Abcam) for 2 h, the
cells were washed twice with PBS and incubated with Alexa Fluor
488-conjugated antibody (1 mg/ml, Invitrogen) for 1.5 h. The
nuclei were stained by 49, 6-diamidino-2-phenylindole (DAPI,
20 mg/ml, Sigma) for 10 min. Images were collected by a digital
camera (DXM 1200; Nikon) attached to a microscope.
Constructs, transfection, and reporter gene assay
The Otx2 cDNA fragment was obtained by RT-PCR and
subcloned into the pcDNA
TM 3.1/myc-His C vector (Invitrogen) to
form the plasmid Otx2-myc-His/pcDNA3.1. 3446mGnRH-LUC
and 2078mGnRH-LUC plasmids were kindly provided by Dr.
Kim (The University of Chicago, USA). The segments of the
Gnrh1 promoter (23446,+23 bp, 22078,+23 bp,
21848,+23 bp, 21134,+23 bp) were digested from
3446mGnRH-LUC and subcloned into the pGL3-Basic vector
to form the plasmids pGL3-P3446, pGL3-P2087, pGL3-P1848,
pGL3-P1134. The fragments of the Gnrh1 promoter
(2520,+23 bp, 2356,+28 bp, 2249,+28 bp), intron 1, intron
2 and intron 3 were amplified by PCR and subcloned into the
pGL3-Basic vector or pGL3-Promoter vector to form the plasmids
pGL3-P520, pGL3-P356, pGL3-P249 and pGL3-Int1–3. The
details of the primers used in construction of plasmids were listed
in Table S2.
The plasmids were transfected into cells using Lipofectamine
2000 (Invitrogen). In Otx2 overexpression experiment, the GT1–7
cells were plated on a 6-well plate (3610
4 cells/well) overnight.
The cells in each well were transfected with 4 mg Otx2-myc-His/
pcDNA3.1 or the corresponding empty vector as a control. In
reporter gene assay, the GT1–7 cells were plated on a 96-well
plate (1.5610
4 cells/well) overnight. The cells in each well were
transfected with 0.4 mg of reporter plasmid or the corresponding
empty vector (pGL3-Basic or pGL3-Promoter) as a control, along
with 20 ng of pRL-SV40 as an internal control reporter. Twenty-
four hours after transfection, HDACIs was added. The gene
expression and the activities of firefly and renilla luciferases (Dual-
Glo
TM Luciferase Assay System, Promega) were detected 24 h
after co-incubation. All experiments were performed in triplicate
and repeated a minimum of three times.
Western blot analysis
Total protein was extracted as described [43]. The nuclear
protein was extracted by NE-PERH Nuclear and Cytoplasmic
Extraction Reagents (Thermo). Equivalent amounts of proteins
(25–40 mg) were separated by 15% SDS-PAGE and transferred
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membranes were sequentially incubated with antibodies overnight
at 4uC. Immunoreactivity was detected with an enhanced
chemiluminescence kit (Millipore). Histone 1 and b-Actin was
used as loading controls.
Chromatin immunoprecipitation (ChIP) assay
ChIP analysis was performed with Chromatin Immunoprecip-
itation (ChIP) Assay Kit (Millipore) according to manufacturer’s
instructions. Briefly, a total of 3610
6 GT1–7 cells in a 10-cm dish
were treated with HDACIs for 24 h and then harvested. Then, the
cells were lysed (200 ml SDS lysis buffer per 1610
6 cells) and
sonicated (200 w for 5 sec with 10 sec interval, 100 cycles) to shear
DNA to lengths between 200 and 1000 bp at ice box. Ten
microliters of anti-Otx2 (Abcam) and anti-Acetyl-H3 (Cell
signaling technology) was used to immunoprecipitate the interact-
ing DNA fragments. The no-antibody immunoprecipitation was
performed as the negative control. Finally, the DNA sample was
used in a PCR reaction. The primers were listed in Table S3.
Electrophoretic mobility shift assay (EMSA)
A total of 3610
6 GT1–7 cells in a 10-cm dish were treated with
HDACIs for 24 h and then harvested. The nuclear protein was
extracted by NE-PERH Nuclear and Cytoplasmic Extraction
Reagents (Thermo). Biotin 59 end-labeled and unlabeled probes
containing the regions of Gnrh1 promoter surrounding the
confirmed Otx2 consensus sites (2268 to 2239 bp and 2330 to
2301 bp) [19,20] were chemosynthesized by Takara biotechnol-
ogy CO. Binding reactions were prepared in EMSA binding buffer
(Pierce) using 10 mg nuclear extract and a 20 fmol biotinylated
probes, used on its own or together with either a cold competitor
unlabeled probes (Cold probes, 4 pmol) or a specific supershift/
blocking antibody (2 mg, Abcam). Reaction mixtures were in-
cubated for 20 min at room temperature. Each sample was
separated by gel eletrophoresis on a 5% nondenaturing poly-
acrylamide gel, and analyzed by chemiluminescence according to
the instructions for LightShiftH Chemiluminescent EMSA Kit
(Pierce).
Statistical analysis
All data were represented as mean 6 SD with at least three
independent experiments. The statistical significances among
groups were analyzed by One-way ANOVA or t-test mostly
comparing all values vs. control group. P,0.05 was considered to
represent a significant difference.
Supporting Information
Table S1 Details of the primers used in the RT-PCR
assay.
(DOC)
Table S2 Details of the primers used in construction of
plasmids.
(DOC)
Table S3 Details of the primers used in ChIP assay.
(DOC)
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